Feil Family Brain & Mind Research Institute

Publications

Found 374 results
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is H  [Clear All Filters]
2020
Parikh NS, Kamel H, Navi BB, Iadecola C, Merkler AE, Jesudian A, Dawson J, Falcone GJ, Sheth KN, Roh DJ et al..  2020.  Liver Fibrosis Indices and Outcomes After Primary Intracerebral Hemorrhage.. Stroke. :STROKEAHA119028161.
Cao X, Tian T, Steele JW, Cabrera RM, Aguiar-Pulido V, Wadhwa S, Bhavani N, Bi P, Gargurevich NH, Hoffman EN et al..  2020.  Loss of RAD9B impairs early neural development and contributes to the risk for human spina bifida.. Hum Mutat.
Faraco G, Hochrainer K, Segarra SG, Schaeffer S, Santisteban MM, Menon A, Jiang H, Holtzman DM, Anrather J, Iadecola C.  2020.  Publisher Correction: Dietary salt promotes cognitive impairment through tau phosphorylation.. Nature.
Faraco G, Hochrainer K, Segarra SG, Schaeffer S, Santisteban MM, Menon A, Jiang H, Holtzman DM, Anrather J, Iadecola C.  2020.  Publisher Correction: Dietary salt promotes cognitive impairment through tau phosphorylation.. Nature.
Jöhr J, Halimi F, Pasquier J, Pincherle A, Schiff N, Diserens K.  2020.  Recovery in cognitive motor dissociation after severe brain injury: A cohort study.. PLoS One. 15(2):e0228474.
Yang J, Ma Q, Dincheva I, Giza J, Jing D, Marinic T, Milner TA, Rajadhyaksha A, Lee FS, Hempstead BL.  2020.  SorCS2 is required for social memory and trafficking of the NMDA receptor.. Mol Psychiatry.
Park L, Hochrainer K, Hattori Y, Ahn SJi, Anfray A, Wang G, Uekawa K, Seo J, Palfini V, Blanco I et al..  2020.  Tau induces PSD95-neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration.. Nat Neurosci. 23(9):1079-1089.
Park L, Hochrainer K, Hattori Y, Ahn SJi, Anfray A, Wang G, Uekawa K, Seo J, Palfini V, Blanco I et al..  2020.  Tau induces PSD95-neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration.. Nat Neurosci. 23(9):1079-1089.
2021
Magid-Bernstein JR, Li Y, Cho S-M, Piran PJ, Roh DJ, Gupta A, Shoamanesh A, Merkler A, Zhang C, Avadhani R et al..  2021.  Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III Trials.. Neurology.
Palmer EE, Whitton C, Hashem MO, Clark RD, Ramanathan S, Starr LJ, Velasco D, De Dios JKarl, Singh E, Cormier-Daire V et al..  2021.  CHEDDA syndrome is an underrecognized neurodevelopmental disorder with a highly restricted ATN1 mutation spectrum.. Clin Genet.
Giacino JT, Bodien YG, Zuckerman D, Henderson J, Schiff ND, Fins JJ.  2021.  Empiricism and Rights Justify the Allocation of Health Care Resources to Persons with Disorders of Consciousness.. AJOB Neurosci. 12(2-3):169-171.
Salsench EMedico, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M et al..  2021.  Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.. Brain.
Aldughaim MS, Al-Anazi MR, Bohol MFe F, Colak D, Alothaid H, Wakil SMajid, Hagos ST, Ali D, Alarifi S, Rout S et al..  2021.  Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis.. Dose Response. 19(2):15593258211019880.
Xu P, Chang JC, Zhou X, Wang W, Bamkole M, Wong E, Bettayeb K, Jiang L-L, Huang T, Luo W et al..  2021.  GSAP regulates lipid homeostasis and mitochondrial function associated with Alzheimer's disease.. J Exp Med. 218(8)
Fins JJ, Wright MS, Giacino JT, Henderson J, Schiff ND.  2021.  In Pursuit of Agency Ex Machina: Expanding the Map in Severe Brain Injury.. AJOB Neurosci. 12(2-3):200-202.
Du H, Wong MYing, Zhang T, Santos MNunez, Hsu C, Zhang J, Yu H, Luo W, Hu F.  2021.  A multifaceted role of progranulin in regulating amyloid-beta dynamics and responses.. Life Sci Alliance. 4(7)
Du H, Wong MYing, Zhang T, Santos MNunez, Hsu C, Zhang J, Yu H, Luo W, Hu F.  2021.  A multifaceted role of progranulin in regulating amyloid-beta dynamics and responses.. Life Sci Alliance. 4(7)
Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.
Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.
Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.
Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.
Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.
Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.
Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.
Yang J, Ma Q, Dincheva I, Giza J, Jing D, Marinic T, Milner TA, Rajadhyaksha A, Lee FS, Hempstead BL.  2021.  SorCS is highly expressed in the CA2 region of the hippocampus and is enriched in the postsynaptic region.. Mol Psychiatry. 26(3):721.